Chilton Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.91K | Hold |
180
| – | – | ﹤0.01% | 477 |
|
|
2025
Q1 | $6.97K | Hold |
180
| – | – | ﹤0.01% | 472 |
|
|
2024
Q4 | $6.09K | Hold |
180
| – | – | ﹤0.01% | 480 |
|
|
2024
Q3 | $7.36K | Hold |
180
| – | – | ﹤0.01% | 500 |
|
|
2024
Q2 | $6.93K | Hold |
180
| – | – | ﹤0.01% | 504 |
|
|
2024
Q1 | $7.72K | Hold |
180
| – | – | ﹤0.01% | 484 |
|
|
2023
Q4 | $6.67K | Hold |
180
| – | – | ﹤0.01% | 491 |
|
|
2023
Q3 | $6.53K | Hold |
180
| – | – | ﹤0.01% | 447 |
|
|
2023
Q2 | $6.42K | Sell |
180
-72
| -29% | -$2.57K | ﹤0.01% | 468 |
|
|
2023
Q1 | $8.97K | Buy |
+252
| New | +$8.97K | ﹤0.01% | 461 |
|
|
2022
Q3 | – | Sell |
-252
| Closed | -$14K | – | 372 |
|
|
2022
Q2 | $14K | Buy |
+252
| New | +$14K | ﹤0.01% | 427 |
|
|
2022
Q1 | – | Sell |
-358
| Closed | -$20K | – | 371 |
|
|
2021
Q4 | $20K | Buy |
+358
| New | +$20K | ﹤0.01% | 418 |
|
|
2020
Q3 | – | Sell |
-12,423
| Closed | -$777K | – | 185 |
|
|
2020
Q2 | $777K | Buy |
+12,423
| New | +$777K | 0.07% | 117 |
|
|
2014
Q1 | – | Sell |
-320
| Closed | -$21.4K | – | 215 |
|
|
2013
Q4 | $21.4K | Hold |
320
| – | – | ﹤0.01% | 287 |
|
|
2013
Q3 | $20.1K | Hold |
320
| – | – | ﹤0.01% | 293 |
|
|
2013
Q2 | $20K | Buy |
+320
| New | +$20K | ﹤0.01% | 301 |
|